Just to add some additional perspective on Jorgens
Post# of 72436
https://finance.yahoo.com/news/cellceutix-ret...00164.html
My opinion is Jorgensen may have stayed on until B phase 3 was set up to go. It's not like he's doing clinical trial work that any of us were aware of...
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)